Research by Wang et al further emphasized that XYDN effectively treats cholestasis-related jaundice and increases SOD enzyme activity in the liver, thereby boosting hepatocyte antioxidative capacity, scavenging free radicals, and preventing liver fibrosis. This evidence concerns the gene SOD1 and cholestasis.